Life Science Analysis: What does Roche’s takeover of Flatiron Health mean?

With Roche being particularly active on the real-world-data front with its recent acquisition of the US cancer data analytics firm Flatiron Health Inc, Healthcare Analyst Tara Raveendran discusses the broader implications of this transaction.

Tara Raveedran’s article was published in the April 2018 edition of MedNous, a publication of Evernow Publishing Ltd, and is available to download here.



Tara Raveendran

Healthcare Analyst, Research

+44 (0)20 7647 8142